Construction of vaccine manufacturing facility

Active Definitive Contract Awarded Last action

Contract number
HHSO100200900101C
Awardee
Awarding agency
Obligated
$1,430,622,665

Award facts

Opportunity
Contract value 62% obligated
  • $1,430,622,665.00 Current, with exercised options
  • $2,291,927,281.00 Potential, with all options
Completion date 71% complete
  • Current, with exercised options
  • Potential, with all options
Contracting staff
Set-aside
No set-aside
Competition
Full and Open Competition · 2 offers Negotiated Proposal / Quote
Pricing
Cost Sharing
Place of performance
Cambridge, MA 02139, USA
Legislative mandates

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Other Administrative Action P00070 $0
Exercise an Option P00069 $80,769,000
Other Administrative Action P00068 $0
Other Administrative Action P00067 $0
Other Administrative Action P00066 · The purpose of this modification is to: $0
Other Administrative Action P00065 · The purpose of this modification is to: 1) at no cost to the government, extend the period of performance end-date for option period 09 from january 31, 2026 to… $0
Other Administrative Action P00064 · The purpose of this modification is to: 1) extend the period of performance for clin 0017 (purchase and delivery of MF59 bulk lots to increase VMI volume) until… $0
Other Administrative Action P00063 · The purpose of this modification is to: 1) update key personnel to the contract (see follow-on page). 2) all other terms and conditions remain the same and in… $0
Exercise an Option P00062 · The purpose of this modification is to: 1) exercise option year 10 (clin 0009J). The period of performance for this option period is june 15, 2025 through… $78,417,000
Funding Only Action P00061 $110,000
Other Administrative Action P00060 · The purpose of this modification is to update the language for section B.2(D), section C.2 milestones, and section H.22 liability protection. The total… $0
Other Administrative Action P00059 · The purpose of this modification is to extend the period of performance for option period 08 to 02/28/2025. $0
Exercise an Option P00058 · The purpose of this modification is incorporate changes and add funds for full investment into the VMI. $121,407,470
Exercise an Option P00057 · The purpose of this modification is to exercise clin 022 and purchase additional lots under clin 017. $20,578,911
Supplemental Agreement for work within scope P00056 · The purpose of this modification is to incorporate additional four (4) option lots. $0
Exercise an Option P00055 · The purpose of this modification is to exercise option year 09 (0009I). $76,133,000
Other Administrative Action P00054 · The purpose of this modification is to transfer of forty-two (42) lots from HHSO100200900101C to 75A50122D00004/75A50124F61010. $0
Other Administrative Action P00053 · The purpose of this modification is to update section F.1 & the period of performance for LI 0009I through 0009Q & add/executed clin 17. $19,441,926
Other Administrative Action P00052 · The purpose of this modification is to incorporate changes to key personnel. $0
Exercise an Option P00051 · The purpose of this modification is to exercise option year 8 (0009H). $73,915,000
Other Administrative Action P00050 · The purpose of this modification is to update lot replacement. $0
Other Administrative Action P00049 · The purpose of this modification is to update key personnel and lot replacement. $0
Exercise an Option P00048 · The purpose of this modification is to exercise OY7 (0009G) $71,763,000
Other Administrative Action P00047 · The purpose of this modification is to formally transfer two inventory batches to 75A50122D0004 and 75A50121F33010. $0
Other Administrative Action P00046 · The purpose of this modification is to update lot pricing. $0
Other Administrative Action P00045 · The purpose of this modification is to update delivery dates for line item 17. $0
Other Administrative Action P00044 · The purpose of this modification is to update key personnel for contract HHSO100200900101C. $0
Other Administrative Action P00043 · The purpose of this modification is to change contracting officer & amend terms and conditions in sections B.4 ownership and use of the facility, C.2… $0
Funding Only Action P00042 · Exercise option year 6,POP JAN 15, 2022 - JAN 14, 2023, to provide a minimum of 2-4 bulk lots of pre-pandemic monovalent influenza vaccine add funding in the… $69,672,000
Funding Only Action P00041 · Fund clin 0014 in the amount $17,087.00 to provide clinical and regulatory support for studies which include MF59 the barda owned VMI $17,087
Other Administrative Action P00040 · The purpose of this modification is to make the changes to the terms and conditions (section B, C and F) $0
Other Administrative Action P00039 · Change CO and COR and add executive order (E.O.) 14042 far deviation clause-52.223-99 ensuring adequate covid-19 safety protocols for federal contractors $0
Other Administrative Action P00038 $0
Other Administrative Action P00037 · The purpose of this modification is to extend the POP for option period 3, due to the delay of the seasonal influenza campaign prioritization by cber, extending… $0
Exercise an Option P00036 · The purpose of this modification is to: exercise option V(OY5)period(january 15,2021 to january 14, 2022) and a minimum of 2 (max 4) pre-pandemic $0.00 bulk… $67,643,000
Supplemental Agreement for work within scope P00035 · The purpose of this modification is to: B. The purpose of this modification is to: 1. Extend option period III (a/hubei WVS), from december 31, 2020 to march… $12,740,271
Supplemental Agreement for work within scope P00034 · The purpose of this modification is to 1) support validation of the small scale filling (SSF) facility, 2) execute an extension to the base period of… $0
Supplemental Agreement for work within scope P00033 · The purpose of this modification is to: 1) extend the period of performance (POP) end date for the option period III of performance, 2) extend the period of… $0
Supplemental Agreement for work within scope P00032 $0
Supplemental Agreement for work within scope P00031 $0
Other Administrative Action P00030 $0
Supplemental Agreement for work within scope P00029 $0
Exercise an Option P00027 $65,673,000
Supplemental Agreement for work within scope P00028 $0
Supplemental Agreement for work within scope P00026 $0
Other Administrative Action 25 $0
Exercise an Option 24 $63,760,000
Other Administrative Action 23 $0
Other Administrative Action 22 $0
Other Administrative Action 21 · Building domestic cell-based influenza vaccine manufacturing facilities $0
Show 40 more

Latest 50 listed here. See the rest on GovTribe.

About this award

Written by GovTribe AI ·

The Office of the Assistant Secretary for Preparedness and Response (HHS ASPR) awarded a $2.29 billion ceiling definitive contract to Seqirus Inc. for construction of a vaccine manufacturing facility on January 15, 2009, under cost-sharing pricing with no set-aside.

A modification dated today extends Option Period 10 from January 31, 2027 to May 31, 2027 at no cost to the government. All other terms and conditions remain unchanged. Ultimate contract completion is January 31, 2034. Place of performance is Cambridge, MA 02139.

Quick answers

Who was awarded contract HHSO100200900101C?

HHSO100200900101C was awarded to Seqirus Inc. by Office of the Assistant Secretary for Preparedness and Response (Department of Health and Human Services) on January 15, 2009.

How much is contract HHSO100200900101C worth?

The government has obligated $1,430,622,665 on HHSO100200900101C. Its potential value, with all options, is $2,291,927,281.

Was contract HHSO100200900101C competed?

The extent of competition for HHSO100200900101C was full and open competition. The government received 2 offers.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award
Try for free Login